FDA Warns Hims Over Ads About Compounded Weight-Loss Drugs

ToplineThe Food and Drug Administration sent warning letters to dozens of drug companies this month, including popular telehealth firm Hims & Hers, demanding they correct “false or misleading claims” about some of their products, targeting the companies just days after President Donald Trump signed an order designed to clamp down on direct-to-consumer drug advertising.Hims was one of dozens of companies that received the warning letters. (Photo illustration by Cheng Xin/Getty Images)Getty Images ...